Treatment of Mild Hyperhomocysteinemia

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-1-4615-5771-5_15
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease.

  1996cited by this paper
• Prevalence of familial mild hyperhomocysteinemia.

  1996cited by this paper
• Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia.

  1995cited by this paper
• Plasma homocysteine in acute myocardial infarction: homocysteine‐lowering effect of folic acid

  1995cited by this paper
• Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects.

  1994cited by this paper
• Vitamin B-6 deficiency vs folate deficiency: comparison of responses to methionine loading in rats.

  1994cited by this paper
• Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia.

  1994cited by this paper
• Hyperhomocysteinaemia: a newly recognized risk factor for vascular disease.

  1994cited by this paper
• Neuropathies à la pyridoxine. Revue de la littérature.

  1994cited by this paper
• Treatment of mild hyperhomocysteinemia in vascular disease patients.

  1994cited by this paper
• Vitamin requirements for the treatment of hyperhomocysteinemia in humans.

  1994cited by this paper
• Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology.

  1993cited by this paper
• Atherosclerotic Cardiovascular Disease, Hemostasis and Endothelial Function

  1993cited by this paper
• A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians.

  1992cited by this paper
• Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease.

  1991cited by this paper
• Hyperhomocysteinemia: an independent risk factor for vascular disease.

  1991cited by this paper
• Diagnosis of cobalamin deficiency.

  1991cited by this paper
• Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment.

  1990cited by this paper
• Diagnosis of cobalamin deficiency I: Usefulness of serum methylmalonic acid and total homocysteine concentrations

  1990cited by this paper
• Folic acid--an innocuous means to reduce plasma homocysteine.

  1988cited by this paper
• Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocystinuria due to cystathionine beta-synthase deficiency.

  1988cited by this paper
• Homocystinuria: A risk factor of premature vascular disease

  1986cited by this paper
• Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease.

  1985cited by this paper
• Detection of heterozygotes for homocystinuria

  1974cited by this paper

• Homocystein im Brennpunkt

  2018cites this paper
• JOURNAL FÜR ERNÄHRUNGSMEDIZIN

  2017cites this paper
• Drugs Affecting Homocysteine Metabolism

  2012cites this paper
• Homocystein im Brennpunkt

  2002cites this paper
• JOURNAL FÜR ERNÄHRUNGSMEDIZIN

  2001cites this paper
• Diagnosis and treatment of hyperhomocysteinemia

  2001cites this paper
• Hyperhomocysteinemia in type 2 diabetes mellitus: cardiovascular risk factors and effect of treatment with folic acid and pyridoxine.

  2000cites this paper
• Betaine-homocysteine methyltransferase (BHMT): genomic sequencing and relevance to hyperhomocysteinemia and vascular disease in humans.

  2000cites this paper
• Homocysteine as a Risk Factor for Atherosclerosis

  2000cites this paper
• Hyperhomocysteinemia and the endocrine system: implications for atherosclerosis and thrombosis.

  1999cites this paper
• Moderate hyperhomocysteinaemia and vascular disease: evidence, relevance and the effect of treatment

  1998cites this paper
• Imaging of vascular pathology in hyperhomocysteinemic patients with digital subtraction angiography and magnetic resonance techniques

  1997cites this paper
• A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

  1995cites this paper